Six-Year Follow-Up Data on CheckMate 227 Survival and Quality of Life Benefits Unveiled for Patients with Metastatic NSCLC and Nivolumab + Ipilimumab Treatment

SINGAPORE, Sept. 10, 2023 /PRNewswire-PRWeb/ -- The International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2023 in Singapore is set to witness a monumental breakthrough in the field of metastatic non-small cell lung cancer (NSCLC) treatment....
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI SVY Source Type: news